TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA

被引：0

作者：

Tabatabai, G. ^{[1
]}

von Baumgarten, L. ^{[2
]}

van den Bent, M. ^{[3
]}

Burger, M. C. ^{[4
,5
]}

Freres, P. ^{[6
]}

Glas, M. ^{[7
]}

Hau, P. ^{[8
]}

Herrlinger, U. ^{[9
]}

Mildenberger, I. ^{[10
]}

Neyns, B. ^{[11
]}

Schaefer, H. ^{[12
]}

Seidel, C. ^{[13
]}

de Vos, F. ^{[14
]}

Galot, R. ^{[15
]}

Whenham, N. ^{[15
]}

Wick, A. ^{[16
]}

Falk, M. ^{[17
]}

Chama, L. de Freitas ^{[18
]}

Henze, J. ^{[17
]}

Kelemen, P. ^{[17
]}

Koch, S. D. ^{[18
]}

Lutz, J. ^{[18
]}

Heidenreich, R. ^{[18
]}

Roche, P. Romer ^{[17
]}

Rost, T. ^{[17
]}

Schoenborn-Kellenberger, O. ^{[17
]}

Gnad-Vogt, U. ^{[17
]}

机构：

[1] Tubingen Univ Hosp, Tubingen, Germany

[2] Ludwig Maximilians Univ Munchen, Neurosurg Clin & Polyclin, Munich, Germany

[3] Erasmus MC Canc Inst, Rotterdam, Netherlands

[4] Goethe Univ Hosp, Frankfurt, Germany

[5] Hosp Frankfurt, Ctr Neurologsurg & Neurooncol, Frankfurt, Germany

[6] Liege Univ Hosp, Frankfurt, Germany

[7] Univ Med Essen, Essen, Germany

[8] Univ Hosp Regensburg, Regensburg, Germany

[9] Univ Bonn, Bonn, Germany

[10] Mannheim Univ, Med Ctr, Mannheim, Germany

[11] Univ Hosp Brussels, Brussels, Belgium

[12] Univ Freiburg, Freiburg, Germany

[13] Univ Hosp Leipzig, Frankfurt, Germany

[14] Univ Med Ctr Utrecht, Frankfurt, Germany

[15] Univ St Luc Hosp, Brussels, Belgium

[16] Heidelberg Univ Hosp, Heidelberg, Germany

[17] CureVac SE, Wiesbaden, Germany

[18] CureVac SE, Tubingen, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P06.09.B

引用

页码：47 / 47

页数：1